1 the principal character in a work of fiction [syn: protagonist]
2 someone involved in a contest or battle (as in an agon) [ant: adversary]
3 a muscle that contracts while another relaxes; "when bending the elbow the biceps are the agonist"
4 (biochemistry) a drug that can combine with a receptor on a cell to produce a physiological reaction
- Someone involved in a contest or battle (as in an agon).
- A muscle that
- "when bending the elbow the biceps are the agonist"
- A molecule that can
combine with a receptor
on a cell to produce a physiological reaction.
- "acetylcholine is an agonist at the a cholinergic receptor"
- For other meanings of 'agonist' or 'agonism', see agonism (disambiguation).
In pharmacology an agonist is a substance that binds to a specific receptor and triggers a response in the cell. It mimics the action of an endogenous ligand (such as hormone or neurotransmitter) that binds to the same receptor.
TypesFull agonists bind (have affinity for) and activate a receptor, displaying full efficacy at that receptor. One example of a drug that acts as a full agonist is isoproterenol which mimics the action of adrenaline at β adrenoreceptors. Another example is morphine, which mimics the actions of endorphins at μ-opioid receptors throughout the central nervous system.
Partial agonists (such as buspirone, aripiprazole, buprenorphine, or norclozapine) also bind and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist. They may also be considered ligands which display both agonistic and antagonistic effects - when both a full agonist and partial agonist are present, the partial agonist actually acts as a competitive antagonist, competing with the full agonist for receptor occupancy and producing a net decrease in the receptor activation observed with the full agonist alone.
An inverse agonist is an agent which binds to the same receptor binding-site as an agonist for that receptor and reverses constitutive activity of receptors. Inverse agonists exert the opposite pharmacological effect of a receptor agonist.
A co-agonist works with other co-agonists to produce the desired effect together. NMDA receptor activation requires the binding of both of its glutamate and glycine co-agonists. An antagonist blocks a receptor from activation by agonists. Clinically partial agonists can activate receptors to give a desired submaximal response when inadequate amounts of the endogenous ligand are present, or they can reduce the overstimulation of receptors when excess amounts of the endogenous ligand are present.
A selective agonist is selective for one certain type of receptor. It can additionally be of any of the aforementioned types.
A physiological agonist is a substance that creates the same bodily responses, but does not bind to the same receptor.
Receptors can be activated or inactivated either by endogenous (such as hormones and neurotransmitters) or exogenous (such as drugs) agonists and antagonists, resulting in stimulating or inhibiting a biological response. To see how an agonist may activate a receptor see this link
New findings that broaden the conventional definition of pharmacology demonstrate that ligands can concurrently behave as agonist and antagonists at the same receptor, depending on effector pathways. Terms that describe this phenomenon are "functional selectivity" or "protean agonism".
PotencyThe potency of an agonist is usually defined by its EC50 value. This can be calculated for a given agonist by determining the concentration of agonist needed to elicit half of the maximum biological response of the agonist. Elucidating an EC50 value is useful for comparing the potency of drugs with similar efficacies producing physiologically similar effects. The lower the EC50, the greater the potency of the agonist the lower the concentration of drug that is required to elicit the maximum biological response
Therapeutic indexWhen a drug is used therapeutically, it is important to understand the margin of safety that exists between the dose needed for the desired effect and the dose that produces unwanted and possibly dangerous side effects. This relationship, termed the therapeutic index, is defined as the ratio LD50:ED50. In general, the narrower this margin, the more likely it is that the drug will produce unwanted effects. The therapeutic index has many limitations, notably the fact that LD50 cannot be measured in humans and, when measured in animals, is a poor guide to the likelihood of unwanted effects in humans. Nevertheless, the therapeutic index emphasizes the importance of the margin of safety, as distinct from the potency, in determining the usefulness of a drug.
EtymologyFrom the Greek αγωνιστής (agōnistēs), contestant; champion; rival < αγων (agōn), contest, combat; exertion, struggle < αγω (agō), I lead, lead towards, conduct; drive
agonist in Arabic: ناهضة (علم الأدوية)
agonist in Catalan: Agonista
agonist in Danish: Agonist
agonist in German: Agonist (Pharmakologie)
agonist in Spanish: Agonista
agonist in French: Agoniste (biochimie)
agonist in Italian: Agonista
agonist in Hebrew: אגוניסט
agonist in Hungarian: Agonista
agonist in Japanese: アゴニスト
agonist in Polish: Agonista
agonist in Russian: Агонист
agonist in Slovenian: Agonist
agonist in Serbian: Агониста
agonist in Finnish: Agonisti
agonist in Swedish: Agonist
agonist in Thai: อะโกนิสต์
agonist in Turkish: Agonist